Speech-Language Pathologists in Holladay, UT Accepting Medicare

6 Speech-Language Pathologists found. Showing 1 - 6

Wasatch Speech & Language Center Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2120 E 3900 S, Suite 100, Holladay, UT 84124 Phone: 801-308-0400    Fax: 801-308-0401

Maria Gurrister, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2120 E 3900 S Ste 100, Holladay, UT 84124 Phone: 801-308-0400    Fax: 801-308-0401

Jennifer Engar Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4782 S Holladay Blvd, Holladay, UT 84117 Phone: 801-277-7002

Mrs. Michelle Flowers, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2120 East 3900 South, Ste 200, Holladay, UT 84124 Phone: 801-308-0400    Fax: 801-308-0401

Ms. Jennifer Leigh Schlendorf, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2240 E Laney Ave Apt 102, Holladay, UT 84117 Phone: 732-232-8671

Speech Superstars, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2240 E Laney Ave Apt 102, Holladay, UT 84117 Phone: 732-232-8671

News Archive

BD second quarter revenues increase 3.6% to $1.991 billion

BD, a leading global medical technology company, today reported quarterly revenues of $1.991 billion for the second fiscal quarter ended March 31, 2012, representing an increase of 3.6 percent from the prior-year period, or 4.6 percent on a foreign currency-neutral basis.

Adjuvants underused initially, follow up needed for cancer patients in pain

Italian study results indicate that physicians underuse adjuvant therapies for treatment of pain in cancer in the first instance, and that close follow up of oncology patients is needed to improve the efficacy of analgesic therapy in this setting.

Medinol introduces NIRxcell CoCr Stent System to coronary marketplace

During the recent 2015 Transcatheter Cardiovascular Therapeutics Meeting held in San Francisco, CA, Medinol Ltd. continued to introduce novel stent solutions to the coronary marketplace. During a satellite symposium, "The BioNIR eDES: The Role of Uniformity in Stent Design to Minimize Restenosis", a renowned physician panel discussed the key attributes of the currently available Medinol NIRxcell CoCr Coronary Stent System and the Medinol eDES Coronary Stent System (in trials, not FDA/CE Mark approved).

New sensor could dramatically improve the efficiency of Covid-19 tests

A new sensor that can give an immediate response to the presence of coronavirus could dramatically improve the efficiency of testing and overcome some of the current surveillance bottlenecks, believe its Swedish developers.

Public and private expenditure in long-term elderly care

The September Policy Brief by Ricardo Rodrigues and Andrea Schmidt aims to present information on the current picture of public and private expenditure on long-term care for older people and to discuss the challenges of financing care. Moreover it provides preliminary results on potential redistribution effects of home care benefits (based on SHARE data).

Read more Medical News

› Verified 9 days ago